Annual SG&A
$1.24B$985.81M+389.64%
Summary
- Current Value
- As of today, GSK annual SG&A is $1.24B, up +389.64% on
- Historical Performance
- GSK annual SG&A is up +423.81% over the past 3 years, up +136.78% over the past 5 years
- All-Time High Comparison
- GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on
- 3-Year Low Comparison
- GSK annual SG&A is +423.81% above its 3-year low of $236.50M reached on an earlier date
- Sector Comparison
- GSK annual SG&A is higher than 98.89% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $1.24B | +389.6% | +423.8% | +136.8% | -93.8% | |
| Quarterly SG&A | $2.86B | +9.5% | +9.7% | -14.7% | -17.4% | |
| TTM SG&A | $54.55B | +287.7% | +421.0% | +280.6% | +173.7% | |
| Price | $49.81 | +36.0% | +37.3% | +27.9% | +13.3% | |
| Annual Operating Expenses | $21.78B | +5.0% | +38.4% | +13.7% | -10.1% | |
| Annual Operating Profit | $9.45B | +30.6% | +14.8% | -10.0% | +22.9% | |
| Annual D&A | $3.05B | -6.5% | +15.3% | +1.1% | +17.7% | |
| Annual Revenue | $43.05B | +7.4% | +19.2% | -1.5% | -1.8% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.24B | at high | |
| 5Y | $1.24B | at high | |
| All | $20.15B | -93.8% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $236.50M | N/A | +423.8% |
| 5Y | $232.43M | +433.0% | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of GSK?
As of today, GSK annual SG&A is $1.24B
What is 1-year change in GSK annual SG&A?
GSK annual SG&A is up +389.64% year-over-year
What is 3-year change in GSK annual SG&A?
GSK annual SG&A is up +423.81% over the past 3 years
How far is GSK annual SG&A from its all-time high?
GSK annual SG&A is currently -93.85% below its historical high of $20.15B set on December 31, 2010
How does GSK annual SG&A rank versus sector peers?
GSK annual SG&A is higher than 98.89% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly SG&A
$2.86B$654.47M-18.65%
Summary
- Current Value
- As of today, GSK quarterly SG&A is $2.86B, down -18.65% on
- Historical Performance
- GSK quarterly SG&A is up +9.53% year-over-year, up +9.65% over the past 3 years
- All-Time High Comparison
- GSK quarterly SG&A is currently -59.34% below its historical high of $7.02B set on
- 3-Year Low Comparison
- GSK quarterly SG&A is +9.65% above its 3-year low of $2.60B reached on an earlier date
- Sector Comparison
- GSK quarterly SG&A is higher than 99.55% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $2.86B | -18.6% | +9.5% | +9.7% | -14.7% | |
| Annual SG&A | $1.24B | – | +389.6% | +423.8% | +136.8% | |
| TTM SG&A | $54.55B | +354.8% | +287.7% | +421.0% | +280.6% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| Quarterly Operating Expenses | $4.85B | -27.2% | +11.7% | +20.6% | +1.5% | |
| Quarterly Operating Profit | $2.90B | +126.0% | +7.7% | +38.1% | +39.9% | |
| Quarterly D&A | $623.84M | -55.1% | -39.8% | -19.8% | +25.3% | |
| Quarterly Revenue | $10.28B | -10.3% | +8.6% | +21.7% | +0.5% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.51B | -18.6% | |
| 3Y | $4.94B | -42.2% | |
| 5Y | $4.94B | -42.2% | |
| All | $7.02B | -59.3% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.61B | N/A | +9.5% |
| 3Y | $2.60B | N/A | +9.7% |
| 5Y | $2.31B | +23.4% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of GSK?
As of today, GSK quarterly SG&A is $2.86B
What is GSK quarterly SG&A most recent change?
GSK quarterly SG&A was down -18.65% on March 31, 2026
What is 1-year change in GSK quarterly SG&A?
GSK quarterly SG&A is up +9.53% year-over-year
How far is GSK quarterly SG&A from its all-time high?
GSK quarterly SG&A is currently -59.34% below its historical high of $7.02B set on December 31, 2010
How does GSK quarterly SG&A rank versus sector peers?
GSK quarterly SG&A is higher than 99.55% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM SG&A
$54.55B$4.56B+9.12%
Summary
- Current Value
- As of today, GSK TTM SG&A is $54.55B, up +9.12% on
- Historical Performance
- GSK TTM SG&A is up +287.74% year-over-year, up +420.96% over the past 3 years
- All-Time High Comparison
- GSK TTM SG&A is currently -9.67% below its historical high of $60.39B set on an earlier date
- 3-Year Low Comparison
- GSK TTM SG&A is +113.79% above its 3-year low of $25.52B reached on an earlier date
- Sector Comparison
- GSK TTM SG&A is higher than 97.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $54.55B | +354.8% | +287.7% | +421.0% | +280.6% | |
| Annual SG&A | $1.24B | – | +389.6% | +423.8% | +136.8% | |
| Quarterly SG&A | $2.86B | -18.6% | +9.5% | +9.7% | -14.7% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| TTM Operating Profit | $9.94B | +2.1% | +37.1% | +29.2% | +15.1% | |
| TTM D&A | $4.59B | -8.3% | +9.4% | +51.6% | +40.5% | |
| TTM Revenue | $43.93B | +1.9% | +9.2% | +25.5% | +3.6% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $54.55B | N/A | at high |
| 3Y | $54.55B | N/A | at high |
| 5Y | $54.55B | N/A | at high |
| All | $60.39B | N/A | -9.7% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $42.32B | N/A | +28.9% |
| 3Y | $25.52B | N/A | +113.8% |
| 5Y | $25.52B | N/A | +113.8% |
| All | -$29.95B | N/A | +282.1% |
TTM SG&A History
FAQ
What is the current TTM SG&A of GSK?
As of today, GSK TTM SG&A is $54.55B
What is GSK TTM SG&A most recent change?
GSK TTM SG&A was up +9.12% on March 31, 2026
What is 1-year change in GSK TTM SG&A?
GSK TTM SG&A is up +287.74% year-over-year
How does GSK TTM SG&A rank versus sector peers?
GSK TTM SG&A is higher than 97.91% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk